Leveljump Healthcare Corp. (JMPHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.72 Million CAD | 132.62% |
| 2022 | 4.18 Million CAD | 15635.67% |
| 2021 | 26.58 Thousand CAD | -78.04% |
| 2020 | 121.02 Thousand CAD | -43.04% |
| 2019 | 212.45 Thousand CAD | -18.22% |
| 2018 | 259.78 Thousand CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 9.12 Million CAD | -3.45% |
| 2024 Q1 | 9.45 Million CAD | -2.85% |
| 2023 Q1 | 5.12 Million CAD | 22.6% |
| 2023 FY | 9.72 Million CAD | 132.62% |
| 2023 Q2 | 4.65 Million USD | -9.15% |
| 2023 Q3 | 5.15 Million USD | 10.75% |
| 2023 Q4 | 9.72 Million CAD | 88.56% |
| 2022 FY | 4.18 Million CAD | 15635.67% |
| 2022 Q4 | 4.18 Million CAD | 19.75% |
| 2022 Q3 | 3.49 Million CAD | -2.72% |
| 2022 Q2 | 3.59 Million CAD | -1.26% |
| 2022 Q1 | 3.63 Million CAD | 13580.61% |
| 2021 Q1 | 113.07 Thousand CAD | -16.64% |
| 2021 FY | 26.58 Thousand CAD | -78.04% |
| 2021 Q4 | 26.58 Thousand CAD | -25.94% |
| 2021 Q3 | 35.88 Thousand CAD | -19.73% |
| 2021 Q2 | 44.7 Thousand CAD | -60.46% |
| 2020 FY | 121.02 Thousand CAD | -43.04% |
| 2020 Q3 | 184.11 Thousand CAD | -16.75% |
| 2020 Q2 | 221.15 Thousand CAD | 0.0% |
| 2020 Q1 | - CAD | -100.0% |
| 2020 Q4 | 135.64 Thousand CAD | -26.32% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q4 | 212.45 Thousand CAD | 0.0% |
| 2019 FY | 212.45 Thousand CAD | -18.22% |
| 2018 FY | 259.78 Thousand CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -334.344% |
| Arrayit Corporation | 1.07 Million USD | -802.393% |
| Atlantic International Corp. | 2.93 Million USD | -232.003% |
| Biocept, Inc. | 12.1 Million USD | 19.652% |
| Bioqual, Inc. | 3.58 Million USD | -171.239% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -13298.663% |
| DermTech, Inc. | 54.39 Million USD | 82.113% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 97.938% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -101.27% |
| iMD Companies, Inc. | 1.12 Million USD | -768.572% |
| IDenta Corp. | 789.14 Thousand USD | -1132.89% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 13.069% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -22090.227% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | -20.937% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -154.302% |
| NovelStem International Corp. | 3.57 Million USD | -172.179% |
| Optigenex Inc. | 8.94 Million USD | -8.82% |
| PharmChem, Inc. | 77.35 Thousand USD | -12477.799% |
| Proteome Sciences plc | 17.15 Million USD | 43.282% |
| Response Genetics, Inc | 6.37 Million USD | -52.664% |
| Rennova Health, Inc. | 15.32 Million USD | 36.532% |
| RushNet, Inc. | 4.82 Million USD | -101.723% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -4599.375% |
| Stella Diagnostics Inc. | 6.2 Million USD | -56.907% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -440.492% |
| Todos Medical Ltd. | 38.34 Million USD | 74.629% |